Clinical trial
The Effect of Working at Home Versus at the Office on Risk of Transmission of SARS-CoV-2 and Other Respiratory Agents. A Randomized Controlled Trial
NCT05298488 is registered in ClinicalTrials.gov with Norwegian Institute of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Working at Home Versus at the Office on Risk of Transmission of SARS-CoV-2 and Other Respiratory Agents. A Randomized Controlled Trial
- Lead sponsor
- Norwegian Institute of Public Health
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 14, 2022
- Completion date
- September 30, 2023
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.